New Attention Deficit Hyperactivity Disorders Findings Has Been Reported by Researchers at Harvard University T.H. Chan School of Public Health (Prenatal antiseizure drug exposure and risk of neurodevelopmental disorders in children: population...).

This article focuses on a population-based cohort study examining the association between prenatal exposure to specific antiseizure drugs and the risk of neurodevelopmental disorders in children. The study, conducted using healthcare data from the United States between 2000 and 2021, evaluated drugs including carbamazepine, lamotrigine, levetiracetam, topiramate, valproate, and zonisamide among pregnant patients with epilepsy. Findings indicated that prenatal exposure to valproate and zonisamide was linked to increased risks of several neurodevelopmental outcomes, while levetiracetam and phenytoin showed no increased risk. Some drugs, such as carbamazepine and oxcarbazepine, were associated with modest increases in attention deficit hyperactivity disorder (ADHD) and behavioral disorders, and potential signals for intellectual disability and learning difficulties were noted for topiramate and lamotrigine. The study underscores the need for further research to confirm these associations, particularly for less common outcomes. [Extracted from the article]